DXCM
Income statement / Annual
Last year (2025), Dexcom Inc's total revenue was $4.66 B,
an increase of 15.60% from the previous year.
In 2025, Dexcom Inc's net income was $836.30 M.
See Dexcom Inc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$4.66 B |
$4.03 B |
$3.62 B |
$2.91 B |
$2.45 B |
$1.93 B |
$1.48 B |
$1.03 B |
$718.50 M |
$573.30 M |
| Cost of Revenue |
$1.86 B
|
$1.59 B
|
$1.33 B
|
$1.03 B
|
$768.00 M
|
$646.60 M
|
$544.50 M
|
$367.70 M
|
$226.40 M
|
$194.90 M
|
| Gross Profit |
$2.80 B
|
$2.44 B
|
$2.29 B
|
$1.88 B
|
$1.68 B
|
$1.28 B
|
$931.50 M
|
$663.90 M
|
$492.10 M
|
$378.40 M
|
| Gross Profit Ratio |
0.6
|
0.6
|
0.63
|
0.65
|
0.69
|
0.66
|
0.63
|
0.64
|
0.68
|
0.66
|
| Research and Development Expenses |
$594.90 M
|
$552.40 M
|
$505.80 M
|
$484.20 M
|
$604.20 M
|
$359.90 M
|
$273.50 M
|
$417.40 M
|
$185.40 M
|
$156.10 M
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$1.29 B
|
$1.29 B
|
$1.19 B
|
$1.01 B
|
$810.50 M
|
$620.70 M
|
$515.70 M
|
$432.80 M
|
$349.20 M
|
$286.20 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$1.89 B
|
$1.84 B
|
$1.69 B
|
$1.49 B
|
$1.41 B
|
$980.60 M
|
$789.20 M
|
$850.20 M
|
$534.60 M
|
$442.30 M
|
| Cost And Expenses |
$3.75 B
|
$3.43 B
|
$3.02 B
|
$2.52 B
|
$2.18 B
|
$1.63 B
|
$1.33 B
|
$1.22 B
|
$761.00 M
|
$637.20 M
|
| Interest Income |
$112.70 M
|
$134.20 M
|
$135.00 M
|
$23.80 M
|
$1.70 M
|
$16.10 M
|
$26.40 M
|
$2.40 M
|
$6.70 M
|
$400.00 K
|
| Interest Expense |
$18.30 M
|
$19.00 M
|
$20.30 M
|
$18.60 M
|
$18.80 M
|
$84.70 M
|
$60.30 M
|
$22.70 M
|
$12.80 M
|
$700.00 K
|
| Depreciation & Amortization |
$251.80 M
|
$217.70 M
|
$186.00 M
|
$155.90 M
|
$101.90 M
|
$67.10 M
|
$48.70 M
|
$29.10 M
|
$16.10 M
|
$15.00 M
|
| EBITDA |
$1.16 B |
$945.70 M |
$916.70 M |
$565.30 M |
$377.50 M |
$376.80 M |
$213.20 M |
-$74.70 M |
-$19.70 M |
-$49.20 M |
| EBITDA Ratio |
0.25
|
0.23
|
0.25
|
0.19
|
0.15
|
0.2
|
0.14
|
-0.07
|
-0.03
|
-0.09
|
| Operating Income Ratio |
0.2
|
0.15
|
0.17
|
0.13
|
0.11
|
0.16
|
0.1
|
-0.18
|
-0.06
|
-0.11
|
| Total Other Income/Expenses Net |
$176.60 M
|
$109.00 M
|
$112.70 M
|
-$400.00 K
|
-$9.00 M
|
-$74.50 M
|
-$38.10 M
|
$59.80 M
|
-$6.10 M
|
-$1.00 M
|
| Income Before Tax |
$1.09 B
|
$709.00 M
|
$710.40 M
|
$390.80 M
|
$256.80 M
|
$225.00 M
|
$104.20 M
|
-$126.50 M
|
-$48.60 M
|
-$64.90 M
|
| Income Before Tax Ratio |
0.23
|
0.18
|
0.2
|
0.13
|
0.1
|
0.12
|
0.07
|
-0.12
|
-0.07
|
-0.11
|
| Income Tax Expense |
$252.10 M
|
$132.80 M
|
$168.90 M
|
$49.60 M
|
$39.90 M
|
-$268.60 M
|
$3.10 M
|
$600.00 K
|
$1.60 M
|
$700.00 K
|
| Net Income |
$836.30 M
|
$576.20 M
|
$541.50 M
|
$341.20 M
|
$216.90 M
|
$493.60 M
|
$101.10 M
|
-$127.10 M
|
-$50.20 M
|
-$65.60 M
|
| Net Income Ratio |
0.18
|
0.14
|
0.15
|
0.12
|
0.09
|
0.26
|
0.07
|
-0.12
|
-0.07
|
-0.11
|
| EPS |
2.14 |
1.46 |
1.44 |
0.88 |
0.56 |
1.31 |
0.28 |
-0.36 |
-0.15 |
-0.2 |
| EPS Diluted |
2.09 |
1.42 |
1.3 |
0.8 |
0.51 |
1.27 |
0.27 |
-0.36 |
-0.15 |
-0.2 |
| Weighted Average Shares Out |
$390.20 M
|
$404.63 M
|
$386.00 M
|
$389.40 M
|
$386.90 M
|
$377.60 M
|
$364.40 M
|
$352.80 M
|
$345.20 M
|
$334.40 M
|
| Weighted Average Shares Out Diluted |
$405.50 M
|
$412.70 M
|
$425.50 M
|
$427.50 M
|
$428.80 M
|
$390.00 M
|
$369.20 M
|
$352.80 M
|
$345.20 M
|
$334.40 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
